Inhibition of Apoptosis of Activated Hepatic Stellate Cells by Tissue Inhibitor of Metalloproteinase-1 Is Mediated via Effects on Matrix Metalloproteinase Inhibition
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
The activated hepatic stellate cell (HSC) is central to liver fibrosis as the major source of collagens I and III and the tissue inhibitors of metalloproteinase-1 (TIMP-1). During spontaneous recovery from liver fibrosis, there is a decrease of TIMP expression, an increase in collagenase activity, and increased apoptosis of HSC, highlighting a potential role for TIMP-1 in HSC survival. In this report, we use tissue culture and in vivo models to demonstrate that TIMP-1 directly inhibits HSC apoptosis. TIMP-1 demonstrated a consistent, significant, and dose-dependent antiapoptotic effect for HSC activated in tissue culture and stimulated to undergo apoptosis by serum deprivation, cycloheximide exposure, and nerve growth factor stimulation. A nonfunctional mutated TIMP-1 (T2G mutant) in which all other domains are conserved did not inhibit apoptosis, indicating that inhibition of apoptosis was mediated through MMP inhibition. Synthetic MMP inhibitors also inhibited HSC apoptosis. Studies of experimental liver cirrhosis demonstrated that persistent expression of TIMP-1 mRNA determined by PCR correlated with persistence of activated HSC quantified by alpha smooth muscle actin staining, while in fibrosis, loss of activated HSC correlated with a reduction in TIMP-1 mRNA. We conclude that TIMP-1 inhibits apoptosis of activated HSC via MMP inhibition.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Concurrently, tissue inhibitors of metalloproteases (TIMPs) produced by HSCs are increased in experimental fibrosis, which could block the activity of their cognate enzymes and also prevent apoptosis of activated HSCs (278, 279).”
From Found in translation—Fibrosis in metabolic dysfunction–associated steatohepatitis (MASH) (2023) · cites this paper as [278]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hengartner, M. O. (2000) · Nature · doi:10.1038/35037710 · Cited by 5,779
Induction of apoptosis in fibroblasts by c-myc protein
Evan, G. I., Wyllie, A. H., Gilbert, C. S., Littlewood, T. D., Land, H., Brooks, M., Waters, C. M., Penn, L. Z., & Hancock, D. C. (1992) · Cell · doi:10.1016/0092-8674(92)90123-t · Cited by 2,935
CD95's deadly mission in the immune system
Krammer, P. H. (2000) · Nature · doi:10.1038/35037728 · Cited by 1,717
The Cellular Basis of Hepatic Fibrosis -- Mechanisms and Treatment Strategies
Flier, J. S., Underhill, L. H., & Friedman, S. L. (1993) · New England Journal of Medicine · doi:10.1056/nejm199306243282508 · Cited by 1,432
Iredale, J. P., Benyon, R. C., Pickering, J., McCullen, M., Northrop, M., Pawley, S., Hovell, C., & Arthur, M. J. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1018 · Cited by 1,075
Self-citationHepatic lipocytes: the principal collagen-producing cells of normal rat liver.
Friedman, S. L., Roll, F. J., Boyles, J., & Bissell, D. M. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.24.8681 · Cited by 859
Docherty, A. J. P., Lyons, A., Smith, B. J., Wright, E. M., Stephens, P. E., Harris, T. J. R., Murphy, G., & Reynolds, J. J. (1985) · Nature · doi:10.1038/318066a0 · Cited by 689
Tanaka, M., Suda, T., Haze, K., Nakamura, N., Sato, K., Kimura, F., Motoyoshi, K., Mizuki, M., Tagawa, S., Ohga, S., et al. (1996) · Nature Medicine · doi:10.1038/nm0396-317 · Cited by 666
Portmann, B. (1998) · Journal of Hepatology · doi:10.1016/s0168-8278(98)80245-6 · Cited by 549
Baker, A. H., Zaltsman, A. B., George, S. J., & Newby, A. C. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1584 · Cited by 464
Research works printed but not linked: 6
- Milani, 1992, Hepatology, 16, 186
- Vyas, 1995, 5, 399
- Saile, 1997, Am. J. Pathol., 151, 1265
- Li, 1999, Cancer Res., 59, 6267
- Ree, 1997, Clin. Cancer Res., 3, 1623
- Trim, 2000, Hepatology, 32, 183
Cited by
Items 201–300 of 431
Effect ofAstragalus complanatusflavonoid on anti-liver fibrosis in rats
Liu, C.-Y., Gu, Z.-L., Zhou, W.-X., & Guo, C.-Y. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i37.5782 · Cited by 40
Czaja, A. J. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.11.037 · Cited by 41
Role of host genetics in fibrosis
Hold, G. L., Untiveros, P., Saunders, K. A., & El-Omar, E. M. (2009) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-2-6 · Cited by 43
Reversal of hepatic fibrosis: pathophysiological basis of antifibrotic therapies
Ismail, M. H., & Pinzani, M. (2011) · Hepatic Medicine Evidence and Research · doi:10.2147/hmer.s9051 · Cited by 47
“matrix degradation, and both collagen and TIMP-1 promote myofibroblast survival.(62,63) Reverse differentiation of the”
Birukawa, N. K., Murase, K., Sato, Y., Kosaka, A., Yoneda, A., Nishita, H., Fujita, R., Nishimura, M., Ninomiya, T., Kajiwara, K., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.544494 · Cited by 40
“In addition, the function of TIMP to inhibit apoptosis of aHSCs was ascribed to their effect on metalloproteinase (8).”
BackgroundOuyang, X., You, S., Zhang, Y., Zhang, C., Zhang, G., Shao, X., He, F., & Hu, L. (2020) · Stem Cells and Development · doi:10.1089/scd.2019.0246 · Cited by 39
Regression of portal hypertension: underlying mechanisms and therapeutic strategies
Selicean, S. E., Wang, C., Guixé‐Muntet, S., Ştefănescu, H., Kawada, N., & Gracia‐Sancho, J. (2021) · Hepatology International · doi:10.1007/s12072-021-10135-4 · Cited by 44
“Moreover, it has been shown that TIMP-1 itself promotes survival of aHSC [64].”
BackgroundNew therapies for hepatic fibrosis
Koyama, Y., & Brenner, D. A. (2015) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2015.06.011 · Cited by 37
Liu, Y., Lui, E. L. H., Friedman, S. L., Li, L., Ye, T., Chen, Y., Poon, R. T. P., Wo, J. Y. H., Kok, T. W., & Fan, S. T. (2008) · Laboratory Investigation · doi:10.1038/labinvest.2008.127 · Cited by 40
“TIMP-1 is involved in the pathogenesis of liver fibrosis and its increase in hepatic fibrosis leads to enhanced survival of activated stellate cells and reduced degradation of interstitial, or ‘scar’ matrix.(40) TIMP-1 forms specific complexes with the proenzyme form of MMP-9.”
Lee, J. I., Lee, K. S., Paik, Y., Park, Y. N., Han, K., Chon, C. Y., & Moon, Y. M. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00411-2 · Cited by 37
Design of a highly potent GLP-1R and GCGR dual-agonist for recovering hepatic fibrosis
Song, N., Xu, H., Liu, J., Zhao, Q., Chen, H., Yan, Z., Yang, R., Luo, Z., Liu, Q., Ouyang, J., et al. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.12.016 · Cited by 39
Duval, F., Moreno-Cuevas, J. E., González‐Garza, M. T., Rodriguez-Montalvo, C. A., & Cruz‐Vega, D. E. (2014) · Chinese Medicine · doi:10.1186/s13020-014-0027-4 · Cited by 39
“TIMP-1 was found to protect HSCs from apoptosis [134].”
BackgroundThorny ground, rocky soil: Tissue-specific mechanisms of tumor dormancy and relapse
Lim, A. R., & Ghajar, C. M. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.05.007 · Cited by 39
Targeting collagen expression in alcoholic liver disease
Thompson, K. J., McKillop, I. H., & Schrum, L. W. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i20.2473 · Cited by 37
Kawada, N. (2006) · Gut · doi:10.1136/gut.2005.090449 · Cited by 36
Hepatosplanchnic circulation in cirrhosis and sepsis
Prin, M., Bakker, J., & Wagener, G. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i9.2582 · Cited by 37
p53 and Myofibroblast Apoptosis in Organ Fibrosis
McElhinney, K., Irnaten, M., & O'Brien, C. J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076737 · Cited by 39
Increases in Fibrosis-Related Gene Transcripts in Livers of Dimethylnitrosamine-Intoxicated Rats
Hsu, Y., Chiu, Y.-T., Lee, C., Lin, Y., & Huang, Y. (2004) · Journal of Biomedical Science · doi:10.1007/bf02254446 · Cited by 34
The strength of the protein-material interaction determines cell fate
González‐García, C., Cantini, M., Ballester‐Beltrán, J., Altankov, G., & Salmerón‐Sánchez, M. (2018) · Acta Biomaterialia · doi:10.1016/j.actbio.2018.07.016 · Cited by 33
Cigarette Smoke Contributes to the Progression of MASLD: From the Molecular Mechanisms to Therapy
Xu, J., Li, Y., Feng, Z., & Chen, H. (2025) · Cells · doi:10.3390/cells14030221 · Cited by 41
“In addition, TIMP-1 can prevent apoptosis of MFBs by inhibiting MMP activity [194].”
Phosphatidylinositol 3-kinase/Akt pathway regulates hepatic stellate cell apoptosis
Wang, Y., Jiang, X., Liu, L., & Jiang, H. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.5186 · Cited by 33
Hu, Q., & Liu, G.-T. (2006) · Life Sciences · doi:10.1016/j.lfs.2006.02.025 · Cited by 33
“TIMP-1 can inhibit collagenase activity, and also inhibits MMP9 and stromelysin activity (Murphy et al., 2002).”
BackgroundDrug choices in autoimmune hepatitis: Part A – steroids
Czaja, A. J. (2012) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/egh.12.40 · Cited by 34
Arendt, E., Ueberham, U., Bittner, R., Gebhardt, R., & Ueberham, E. (2005) · Cell Proliferation · doi:10.1111/j.1365-2184.2005.00350.x · Cited by 33
“This might also support rapid removal of activated hepatic stellate cells, the main producers of deposited matrix in liver tissue, because timp-1 has been shown to independently prevent apoptosis in this cell type (Murphy et al. 2002).”
BackgroundTaşçı, İ., Mas, M. R., Vural, S. A., Cömert, B., Alcigir, G., Serdar, M. A., Mas, N., Işık, A. T., & Ateş, Y. (2006) · Liver International · doi:10.1111/j.1478-3231.2005.01210.x · Cited by 33
“Although TIMPs were reported to inhibit apoptosis of several cell types independent of collagenase inhibition (37, 38), there is an antiapoptotic activity of these proteins on activated HSCs mediated through inhibitory effects on MMPs (18).”
BackgroundInfluentialCompound Danshen Dripping Pill Inhibits Retina Cell Apoptosis in Diabetic Rats
Zhang, Q., Xiao, X., Zheng, J., Li, M., Yu, M., Ping, F., Wang, T., & Wang, X. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01501 · Cited by 32
You Say You Want a Resolution (of Fibrosis)
Atabai, K., Yang, C. D., & Podolsky, M. J. (2020) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2020-0182tr · Cited by 31
Stevenson, T. J., Vinarsky, V., Atkinson, D. L., Keating, M. T., & Odelberg, S. J. (2005) · Developmental Dynamics · doi:10.1002/dvdy.20654 · Cited by 31
“Human TIMP1 has also been shown to be a cell survival factor for several cell types (Alexander et al., 1996; Li et al., 1999; Murphy et al., 2002; Yoshiji et al., 2002), as well as an enhancer or inhibitor of bone resorption depending on whether TIMP1 concentrations are low or high, respectively…”
BackgroundVainshtein, J. M., Kabarriti, R., Mehta, K., Roy‐Chowdhury, J., & Guha, C. (2014) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2014.02.017 · Cited by 31
Lin, W. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i15.2369 · Cited by 32
Targeting Hepatic Fibrosis in Autoimmune Hepatitis
Montaño‐Loza, A. J., Thandassery, R. B., & Czaja, A. J. (2016) · Digestive Diseases and Sciences · doi:10.1007/s10620-016-4254-7 · Cited by 32
Sørensen, I. V., Fenger, C., Winther, H., Foged, N. T., Lademann, U. A., Brünner, N., & Usher, P. A. (2006) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.5a6896.2006 · Cited by 31
“…also exhibits several other biological functions including stimulation of proliferation in various cell types (Brew et al. 2000; Fassina et al. 2000; Lafleur et al. 2003) and inhibition of apoptosis (Guedez et al. 1998; Li et al. 1999; Murphy et al. 2002; Lambert et al. 2003; Liu et al. 2003).”
BackgroundXu, G. (2004) · World Journal of Gastroenterology · doi:10.3748/wjg.v10.i24.3621 · Cited by 30
The TIMP protein family: diverse roles in pathophysiology
Coates-Park, S., Rich, J. A., Stetler‐Stevenson, W. G., & Peeney, D. (2024) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00699.2023 · Cited by 36
Therapeutic developments in matrix metalloproteinase inhibition
Shah, P. K., Wilkin, D. J., Doherty, T. M., Uzui, H., Rajavashisth, T. B., Asotra, K., & Pei, D. (2002) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.12.5.665 · Cited by 30
MicroRNA-21/PTEN/Akt axis in the fibrogenesis of biliary atresia
Shen, W., Chen, G., Dong, R., Zhao, R., & Zheng, S. (2014) · Journal of Pediatric Surgery · doi:10.1016/j.jpedsurg.2014.09.009 · Cited by 28
Hashem, A. M., Rasmy, M., Wahba, K., & Shaker, O. G. (2011) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2011.10.005 · Cited by 28
Mafanda, E. K., Kandhi, R., Bobbala, D., Khan, M. G. M., Nandi, M., Menéndez, A., Ramanathan, S., & Ilangumaran, S. (2018) · Cytokine · doi:10.1016/j.cyto.2018.07.032 · Cited by 30
Brougham‐Cook, A., Jain, I., Kukla, D. A., Masood, F., Kimmel, H., Ryoo, H., Khetani, S. R., & Underhill, G. H. (2021) · SSRN Electronic Journal · doi:10.1016/j.actbio.2021.11.015 · Cited by 35
AJWA DATES AS A PROTECTIVE AGENT AGAINST LIVER TOXICITY IN RAT
Sheikh, B. Y., Elsaed, W. M., Samman, A. H., Sheikh, B. Y., & Ladin, A.-M. M. B. (2014) · European Scientific Journal ESJ · Cited by 27
Carvedilol Attenuates the Progression of Hepatic Fibrosis Induced by Bile Duct Ligation
Tian, X., Zhao, C., Guo, J., Xie, S., Yin, F., Huo, X., & Zhang, X. (2017) · BioMed Research International · doi:10.1155/2017/4612769 · Cited by 28
“TIMP-1 not only restrains the ability of MMPs, but also inhibits the apoptosis of activated HSCs [18].”
BackgroundHo, C.-H., Huang, J.-H., Sun, M.-S., Tzeng, I., Hsu, Y., & Kuo, C. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/6671129 · Cited by 31
Antiproliferative mechanisms of quercetin in rat activated hepatic stellate cells
Wu, L.-C., Lu, I.-W., Chung, C.-F., Wu, H.-Y., & Liu, Y. (2011) · Food & Function · doi:10.1039/c0fo00158a · Cited by 26
Gnainsky, Y., Spira, G., Paizi, M., Bruck, R., Nagler, A., Abu-Amara, S. N., Geiger, B., Genina, O., Ornan, E. M., & Pines, M. (2003) · Journal of Hepatology · doi:10.1016/j.jhep.2003.10.020 · Cited by 25
Abdalla, A. F., Zalata, K. R., Ismail, A. F., Shiha, G. E.-S., Attiya, M., & Abo-Alyazeed, A. (2009) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-2-2 · Cited by 25
“Suppression of inflammatory activity promotes disappearance of the metalloproteinase inhibitors, degradation of the fibrotic liver matrix by unrestricted metalloproteinases, and apoptosis of the hepatic stellate cells [ 29 ,30].”
BackgroundRajagopalan, R., Sridharana, S., & Menon, V. P. (2010) · Toxicology Mechanisms and Methods · doi:10.3109/15376516.2010.482961 · Cited by 25
“Disruption of MMP/TIMP balance can lead to excessive accumulation of ECM components resulting in severe liver injury (Murphy et al. 2002).”
BackgroundGentilini, A., Lottini, B., Brogi, M., Caligiuri, A., Cosmi, L., Marra, F., & Pinzani, M. (2009) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-2-1 · Cited by 25
Girão-Silva, T., Bassaneze, V., Campos, L. C. G., Baraúna, V. G., Dallan, L. A. O., Krieger, J. E., & Miyakawa, A. A. (2014) · BioMedical Engineering OnLine · doi:10.1186/1475-925x-13-54 · Cited by 24
“the ability to induce growth of endothelial cells and anti-apoptotic activity [46-50].”
BackgroundChang, X.-M. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i17.2634 · Cited by 25
Langlois, S., Tomasso, G. D., Boivin, D., Roghi, C., Murphy, G., Gingras, D., & Béliveau, R. (2005) · Experimental Cell Research · doi:10.1016/j.yexcr.2005.04.007 · Cited by 24
“Inhibition of MMPs by BB94 blocks lethal hepatitis and apoptosis induced by tumor necrosis factor in vivo [59], and the endogenous tissue inhibitor of metalloproteinase-1 (TIMP-1) have been shown to inhibit apoptosis through inhibition of MMPs activity in hepatic stellate cells [60].”
BackgroundBonfitto, N. L. B., Motta, A. C. F., Furini, R. B., Komesu, M. C., do Nascime, M. M. P., Figueiredo, J. F. C., & Foss, N. T. (2009) · American Journal of Infectious Diseases · doi:10.3844/ajidsp.2009.314.319 · Cited by 23
“The homeostasis of ECM is important for normal function of many organs and remodeling by MMPs is essential in diverse physiological processes including angiogenesis and wound healing([7]).”
Rieder, F., Bettenworth, D., Imai, J., & Inagaki, Y. (2016) · Inflammatory Intestinal Diseases · doi:10.1159/000445135 · Cited by 27
Immunological and molecular aspects of liver fibrosis in chronic hepatitis C virus infection.
Giannelli, G., & Antonaci, S. (2005) · PubMed · doi:10.14670/hh-20.939 · Cited by 26
Ohayon, O., Mawasi, N., Pevzner, A., Tryvitz, A., Gildor, T., Pines, M., Rojkind, M., Paizi, M., & Spira, G. (2008) · Laboratory Investigation · doi:10.1038/labinvest.2008.30 · Cited by 22
“3 Chemically induced experimental liver fibrosis could be a reversible process when the pathogenic trigger is removed”
BackgroundZhang, L., Chen, Y.-X., Chen, Z.-X., Huang, Y.-H., Yu, J.-P., & Wang, X.-Z. (2004) · World Journal of Gastroenterology · doi:10.3748/wjg.v10.i17.2574 · Cited by 24
Plasticity, heterogeneity, and multifunctionality of hepatic stellate cells in liver pathophysiology
Du, K., Jun, J. H., Dutta, R. K., & Diehl, A. M. (2024) · Hepatology Communications · doi:10.1097/hc9.0000000000000411 · Cited by 31
“[59] Moreover, TIMP1 and TGF β , which are upregulated in activated HSCs, serve as antiapoptotic signals, promoting the survival of HSCs. [60] Our recent scRNA-seq analysis of HSCs from chronic CCl 4 and BDL models has revealed intriguing insights.”
BackgroundMatsuzaki, S., Pouly, J. L., & Canis, M. J. (2022) · Human Reproduction · doi:10.1093/humrep/deac248 · Cited by 28
van Riet, S., Julien, A., Atanasov, A., Nordling, Å., & Ingelman‐Sundberg, M. (2024) · Hepatology Communications · doi:10.1097/hc9.0000000000000374 · Cited by 27
High preoperative plasma TIMP‐1 is prognostic for early relapse in primary breast carcinoma
Kuvaja, P., Talvensaari‐Mattila, A., & Turpeenniemi-Hujanen, T. M. (2008) · International Journal of Cancer · doi:10.1002/ijc.23531 · Cited by 22
Würtz, S. Ø., Christensen, I. J., Schrohl, A.-S., Mouridsen, H. T., Lademann, U. A., Jensen, V., & Brünner, N. (2005) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m400209-mcp200 · Cited by 22
Guo, S.-G., Zhang, W., Jiang, T., Dai, M., Zhang, L.-F., Meng, Y., Zhao, L.-Y., & Niu, J.-Z. (2004) · World Journal of Gastroenterology · doi:10.3748/wjg.v10.i10.1487 · Cited by 21
The heat shock protein 90 inhibitor, 17-AAG, attenuates thioacetamide induced liver fibrosis in mice
Abu‐Elsaad, N., Serrya, M. S., El-Karef, A., & Ibrahim, T. M. (2015) · Pharmacological Reports · doi:10.1016/j.pharep.2015.08.015 · Cited by 22
El‐Kamary, S. S., Mohamed, M. M., Raziky, M. E., Shardell, M. D., Shaker, O. G., Elakel, W., & Esmat, G. (2013) · Liver International · doi:10.1111/liv.12139 · Cited by 23
“For Step 1 (F0/F1 vs. F2/F3/F4, training n = 237), the random forest found that HA, TGF-b1, a2M, ApoA1, MMP-2, TIMP-1, MMP-1, AFP, age and urea resulted in >0.5% improvement in accuracy, in order of greatest to smallest improvement.”
BackgroundInfluentialWang, Q., Liu, X.-S., Zhang, J., Lü, L., Feng, M., & Wang, J. (2019) · Molecular Medicine Reports · doi:10.3892/mmr.2019.10740 · Cited by 28
“Other studies have indicated that MMPs have a critical role in the apoptosis of activated HSCs, or facilitate the generation of restorative macrophages, which has been proven to promote fibrosis resolution (17,18).”
Kohjima, M., Enjoji, M., Higuchi, N., Kotoh, K., Kato, M., Takayanagi, R., & Nakamuta, M. (2007) · Liver International · doi:10.1111/j.1478-3231.2007.01560.x · Cited by 22
Fraczek, J., van Grunsven, L. A., Vinken, M., Sarah, S., Deleu, S., Vanderkerken, K., Vanhaecke, T., & Rogiers, V. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00831.x · Cited by 23
“Apart from the direct effect on of the ECM degradation rate, TIMP-1 also acts as an anti-apoptotic factor for activated HSCs [144].”
BackgroundRoeb, E. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i8.1096 · Cited by 21
Vasiliou, V., Qamar, L., Pappa, A., Sophos, N. A., & Petersen, D. R. (2003) · Archives of Biochemistry and Biophysics · doi:10.1016/s0003-9861(03)00095-x · Cited by 20
Approaches for treatment of liver fibrosis in chronic hepatitis C
Bédossa, P., & Paradis, V. (2003) · Clinics in Liver Disease · doi:10.1016/s1089-3261(02)00076-4 · Cited by 22
HIV-Infected Lymphocytes Regulate Fibronectin Synthesis by TGFβ1 Secretion
Pal, S., & Schnapp, L. M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.5.3189 · Cited by 20
“Animal models of liver fibrosis also show that improvement of established fibrosis is possible (22, 23).”
BackgroundDeveloping strategies for liver fibrosis treatment
Murphy, F. R., Arthur, M. J. P., & Iredale, J. P. (2002) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.11.11.1575 · Cited by 20
“Activated HSC also prevent their apoptosis by autocrine production of TIMP-1 which has recently been shown to prevent apoptosis of activated HSC through its effect on MMP inhibition [40].”
BackgroundSelf-citationRojkind, M., & Reyes‐Gordillo, K. (2009) · Wiley eBooks · doi:10.1002/9780470747919.ch28 · Cited by 21
Inflammation and MMPs in alcohol-induced liver diseases and protective action of antioxidants.
Banerjee, P., Jana, S., Chakraborty, S., & Swarnakar, S. (2013) · PubMed · Cited by 24
Atat, O. E., Antonios, D., Hilal, G., Hokayem, N. E., Ghoch, J. A., Hashim, H., Serhal, R., Hebbo, C., Moussa, M., & Alaaeddine, N. (2016) · PLoS ONE · doi:10.1371/journal.pone.0162332 · Cited by 22
Noninvasive Tests for Liver Fibrosis
Mukherjee, S., & Sorrell, M. F. (2006) · Seminars in Liver Disease · doi:10.1055/s-2006-951598 · Cited by 19
Regression of Allograft Airway Fibrosis
Sato, M., Hwang, D. M., Guan, Z., Yeung, J. C., Anraku, M., Wagnetz, D., Hirayama, S., Waddell, T. K., Liu, M., & Keshavjee, S. H. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.05.032 · Cited by 19
Wang, X., Zhang, S.-J., Chen, Y.-X., Chen, Z.-X., Huang, Y.-H., & Zhang, L.-J. (2004) · World Journal of Gastroenterology · doi:10.3748/wjg.v10.i18.2706 · Cited by 21
Li, J. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i41.6483 · Cited by 19
Yamazaki, M. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh181 · Cited by 19
Insulin-like growth factor 1 enhances bile-duct proliferation and fibrosis in Abcb4−/− mice
Sokolović, A., Rodríguez‐Ortigosa, C. M., ten Bloemendaal, L., Elferink, R. P. J. O., Prìeto, J., & Bosma, P. J. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.02.005 · Cited by 19
Lin, M., Chang, Y., Xie, F., Shi, Y., Pang, L., & Chen, D. (2017) · Digestive Diseases and Sciences · doi:10.1007/s10620-017-4816-3 · Cited by 19
Gao, Y., Li, X., Gao, Q., Fan, L., Jin, H., & Guo, Y. (2019) · Bioscience Reports · doi:10.1042/bsr20191913 · Cited by 18
Wound healing and local neuroendocrine regulation in the injured liver
Ebrahimkhani, M. R., Elsharkawy, A. M., & Mann, D. A. (2008) · Expert Reviews in Molecular Medicine · doi:10.1017/s146239940800063x · Cited by 20
Zvibel, I., Bar-Zohar, D., Kloog, Y., Oren, R., & Reif, S. S. (2007) · Digestive Diseases and Sciences · doi:10.1007/s10620-007-9984-0 · Cited by 19
“It has been shown that activity of MMP-2 is associated with enhanced proliferation of hepatic stellate cells [32], while MMP-9 has been shown to induce apoptosis of hepatic stellate cells by binding TIMP-1, which is a survival factor for the cells [33–35].”
Cell-ECM Interactions in Repair and Regeneration
Petreaca, M. L., & Martins‐Green, M. M. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-381422-7.10002-1 · Cited by 18
Galatou, E., Mourelatou, E. A., Hatziantoniou, S., & Vizirianakis, I. S. (2022) · Antioxidants · doi:10.3390/antiox11061060 · Cited by 19
“Upon HSC proliferation, components of the extracellular matrix are produced, including collagen type I and type III as well as tissue inhibitor of metalloproteinases 1 (TIMP-1), all contributing to fibrogenesis [74,75].”
BackgroundInhibitory effect of immature plum on PMA-induced MMP-9 expression in human hepatocellular carcinoma
Yu, M.-H., Im, H.-G., Lee, S., Kim, D., Seo, H. J., & Lee, I. (2009) · Natural Product Research · doi:10.1080/14786410802263485 · Cited by 17
“It has been well established that TIMP-1 has anti-apoptotic activity on many different cell types through both MMP-dependent (Murphy et al., 2002; Vorotnikova, Tries, & Braunhut, 2004) and -independent pathways (Lambert et al., 2003; Liu et al., 2005).”
BackgroundBiomarkers in Liver Disease: Emerging Methods and Potential Applications
Aithal, G. P., Guha, I. N., Fallowfield, J. A., Castéra, L., & Jackson, A. P. (2012) · International Journal of Hepatology · doi:10.1155/2012/437508 · Cited by 19
Emerging Concepts in Inflammation and Fibrosis
Gutiérrez‐Ruíz, M. C., Robles‐Díaz, G., & Kershenobich, D. (2002) · Archives of Medical Research · doi:10.1016/s0188-4409(02)00408-3 · Cited by 17
Iwanaga, T., Chiba, T., Nakamura, M., Kaneko, T., Ao, J., Qiang, N., Ma, Y., Zhang, J., Kogure, T., Yumita, S., et al. (2022) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2022.12.025 · Cited by 15
A humanized mouse model of liver fibrosis following expansion of transplanted hepatic stellate cells
Benten, D., Kluwe, J., Wirth, J. W., Thiele, N. D., Follenzi, A., Bhargava, K. K., Palestro, C. J., Koepke, M., Tjandra, R., Volz, T., et al. (2018) · Laboratory Investigation · doi:10.1038/s41374-017-0010-7 · Cited by 17
Wang, J., Zhou, X., Cui, L., Li, Y., Liang, J., Cheng, X., Qiao, L., Shi, Y., Han, Z., Cao, Y., et al. (2010) · Cytotherapy · doi:10.3109/14653249.2010.515578 · Cited by 17
Self-citationLuna, J., Masamunt, M. C., Lawrance, I. C., & Sans, M. (2011) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00504.2010 · Cited by 17
“TIMP-1 suppresses HSC apoptosis both in vitro and in vivo (51), highlighting a potential role for HSC survival in liver fibrosis.”
BackgroundNiu, X., Wang, X., Niu, B., Meng, Y., He, H., Wang, Y., & Li, G. (2021) · Pharmaceuticals · doi:10.3390/ph14100951 · Cited by 16
Lee, M., Jung, J.-I., Kwon, S., Lee, S. M., Morita, K., & Her, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035710 · Cited by 15
“Numerous studies have considered to these two defects as cancer targets, whereas the effects of TIMPs on cell proliferation or apoptosis have been restricted to cell-based experiments and elicited divergent effects even in the same cell types [44], [45], [46], [47].”
BackgroundExpression of matrix metalloproteinase and its tissue inhibitor in haemangioma
Zhong, S., Yang, G., Xia, C., Duanlian, Z., & Shan, S.-G. (2009) · Journal of Huazhong University of Science and Technology [Medical Sciences] · doi:10.1007/s11596-009-0516-3 · Cited by 14
Retamal, I. N., Hernández, R., González‐Rivas, C., Cáceres, M., Arancibia, R., Romero, A., Martínez, C., Tobar, N., Martínez, J., & Smith, P. C. (2016) · Journal of Periodontal Research · doi:10.1111/jre.12365 · Cited by 14
Targeting siRNA to arrest fibrosis
Friedman, S. L. (2008) · Nature Biotechnology · doi:10.1038/nbt0408-399 · Cited by 14
Kim, S. Y., Lamichhane, S., Ju, J. H., & Yun, J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19071836 · Cited by 13
“It was report that the inhibition of apoptosis by tissue inhibitor of metalloproteinase-1 (TIMP-1) was mediated by the inhibition of MMPs in hepatic cells [27,28].”
BackgroundNiu, X., Wang, X., Niu, B., Li, G., Yang, X., Yang, X., & Li, G. (2021) · Molecules · doi:10.3390/molecules26061545 · Cited by 13
“TGF-β1 polyclonal antibody was purchased from Abnova (Abnova, USA).”
BackgroundInfluential
Metadata
- Authors
- Murphy, F. R., Issa, R., Zhou, X., Ratnarajah, S., Arthur, M. J. P., Benyon, C., Iredale, J. P., & Nagase, H.
- Affiliations
- University of Southampton (GB)
- Imperial College London (GB)
- Corresponding author
- Murphy, Frank R.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2002-03
- Volume
- 277
- Issue
- 13
- Pages
- 11069-11076
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2164407945
- Cited by
- 432
- References
- 42
- Citations by year
- 2026: 7 · 2025: 13 · 2024: 4 · 2023: 7 · 2022: 11 · 2021: 12 · 2020: 8 · 2019: 9 · 2018: 18 · 2017: 12 · 2016: 16 · 2015: 24 · 2014: 20 · 2013: 19 · 2012: 20
- FWCI
- 21.47
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6800 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- ePrints Soton (University of Southampton) (submittedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Keywords
- TIMP-1, hepatic stellate cells, apoptosis, matrix metalloproteinase inhibition, liver fibrosis, liver cirrhosis, alpha-smooth muscle actin, collagenase, serum deprivation, cycloheximide, nerve growth factor, TIMP-1 mRNA expression
- MeSH terms
- Animals, Cell Division, Cells, Cultured, Cycloheximide, Humans, Liver, Liver Cirrhosis, Apoptosis, Tissue Inhibitor of Metalloproteinase-1, Caspases, In Situ Nick-End Labeling, Rats, Caspase 3, Matrix Metalloproteinase Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.